{"id":"placebo-cap","safety":{"commonSideEffects":[{"rate":null,"effect":"Nocebo effects (adverse events attributed to placebo expectation)"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Placebo is an inert substance with no active pharmaceutical ingredient. Its therapeutic effects, when observed, arise from patient expectation, conditioning, and psychobiological mechanisms rather than direct molecular action. It is commonly used as a control in clinical trials to measure the true efficacy of active drugs.","oneSentence":"Placebo produces no pharmacological effect and works through psychological expectation and the placebo response.","_ai_confidence":"high"},"_scrapedAt":"2026-03-27T23:36:06.672Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Clinical trial control / comparator"}]},"trialDetails":[{"nctId":"NCT07496021","phase":"NA","title":"Safety and Efficacy of L. Lactis CKDB001 in Subjects With Early Alzheimer's Disease","status":"RECRUITING","sponsor":"CKD Bio Corporation","startDate":"2026-02-23","conditions":"Early Alzheimers Disease","enrollment":60},{"nctId":"NCT07135232","phase":"NA","title":"The Effects of Resistance Training and a Plant-Based Supplement on Perimenopausal Symptoms and Muscle Health.","status":"RECRUITING","sponsor":"Leeds Beckett University","startDate":"2026-03-01","conditions":"Perimenopause, Menopause","enrollment":72},{"nctId":"NCT07494279","phase":"NA","title":"Efficacy of Nigella Sativa (Nisatol®) in Women With Borderline Blood Pressure Values or a Non-Dipper Blood Pressure Phenotype","status":"NOT_YET_RECRUITING","sponsor":"Liaquat University of Medical & Health Sciences","startDate":"2026-03-30","conditions":"Prehypertension, Hypertension","enrollment":106},{"nctId":"NCT06898606","phase":"PHASE1, PHASE2","title":"Psilocybe Cubensis Mushrooms With or Without Fluoxetine for Refractory Depression","status":"RECRUITING","sponsor":"Federal University of Latin American Integration","startDate":"2024-09-05","conditions":"Depressive Disorder","enrollment":24},{"nctId":"NCT06456346","phase":"PHASE3","title":"Bomedemstat vs Hydroxyurea for Essential Thrombocythemia (MK-3543-007)","status":"RECRUITING","sponsor":"Merck Sharp & Dohme LLC","startDate":"2024-07-16","conditions":"Essential Thrombocythemia","enrollment":300},{"nctId":"NCT03574909","phase":"PHASE3","title":"IRELAnD: Investigating the Role of Early Low-dose Aspirin in Diabetes","status":"COMPLETED","sponsor":"Royal College of Surgeons, Ireland","startDate":"2018-09-01","conditions":"Pre-Gestational Diabetes","enrollment":137},{"nctId":"NCT04199104","phase":"PHASE3","title":"A Study of Pembrolizumab (MK-3475) With or Without Lenvatinib (E7080/MK-7902) as First Line (1L) Intervention in a Programmed Cell Death-ligand 1 (PD-L1) Selected Population With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma (R/M HNSCC) (MK-7902-010) (KEYNOTE-010)","status":"COMPLETED","sponsor":"Merck Sharp & Dohme LLC","startDate":"2020-02-05","conditions":"Head and Neck Squamous Cell Carcinoma","enrollment":511},{"nctId":"NCT07498712","phase":"NA","title":"Effect of L. Reuteri LM1063 on Sleep Health Improvement","status":"RECRUITING","sponsor":"Lactomason Co., Ltd.","startDate":"2025-07-14","conditions":"Sleep Quality, Sleep Wake Disorders","enrollment":80},{"nctId":"NCT06631287","phase":"PHASE3","title":"Randomized Double-Blind Placebo-Controlled Trial EValuating Baricitinib on PERSistent NEurologic and Cardiopulmonary Symptoms of Long COVID","status":"RECRUITING","sponsor":"Wes Ely","startDate":"2024-10-21","conditions":"Long COVID, Sars-CoV-2 Infection, Coronavirus Infections","enrollment":550},{"nctId":"NCT06072183","phase":"PHASE3","title":"A 104-Week Study of Ritlecitinib Oral Capsules in Adults With Nonsegmental Vitiligo (Active and Stable) Tranquillo 2","status":"ACTIVE_NOT_RECRUITING","sponsor":"Pfizer","startDate":"2023-11-08","conditions":"Stable Nonsegmental Vitiligo, Active Nonsegmental Vitiligo","enrollment":1571},{"nctId":"NCT07266831","phase":"PHASE2, PHASE3","title":"A Clinical Study of Islatravir and Ulonivirine for People With HIV-1 Who Have Not Been Treated Before (MK-8591B-062)","status":"RECRUITING","sponsor":"Merck Sharp & Dohme LLC","startDate":"2025-12-18","conditions":"Human Immunodeficiency Virus Type 1 (HIV-1) Infection","enrollment":570},{"nctId":"NCT06450366","phase":"PHASE3","title":"A Study to Evaluate the Efficacy and Safety of Enlicitide (MK-0616, Oral PCSK9 Inhibitor) Compared With Ezetimibe or Bempedoic Acid or Ezetimibe and Bempedoic Acid in Adults With Hypercholesterolemia (MK-0616-018/CORALreef AddOn)","status":"COMPLETED","sponsor":"Merck Sharp & Dohme LLC","startDate":"2024-07-08","conditions":"Hypercholesterolemia","enrollment":301},{"nctId":"NCT07497685","phase":"NA","title":"Effects of Different Caffeine Forms on Aerobic and Anaerobic Exercise Performance","status":"COMPLETED","sponsor":"University of Gaziantep","startDate":"2024-10-10","conditions":"Exercise Performance, Physical Performance","enrollment":14},{"nctId":"NCT07496502","phase":"PHASE1, PHASE2","title":"Effect of Oral Microbiota on MDRO Decolonization","status":"COMPLETED","sponsor":"Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran","startDate":"2022-03-31","conditions":"Clostridioides Difficile Infection, Drug Resistance, Bacterial, Gastrointestinal Microbiome","enrollment":42},{"nctId":"NCT04781387","phase":"PHASE2","title":"Evaluation of CRS3123 vs. Oral Vancomycin in Adult Patients With Clostridioides Difficile Infection","status":"COMPLETED","sponsor":"Crestone, Inc","startDate":"2021-01-05","conditions":"Clostridioides Difficile Infection","enrollment":43},{"nctId":"NCT07495592","phase":"NA","title":"The Acute Effects of Onnit Alpha Brain on Cognition and Mood States","status":"NOT_YET_RECRUITING","sponsor":"Applied Science & Performance Institute","startDate":"2026-04-16","conditions":"Cognitive, Mood and Cognitive Performance, Sleep Deprivation","enrollment":34},{"nctId":"NCT07332091","phase":"PHASE2","title":"Efficacy and Safety of Vamifeport in Adult Participants With Homeostatic Iron Regulator Gene (HFE)-Related Hereditary Hemochromatosis","status":"RECRUITING","sponsor":"CSL Behring","startDate":"2026-01-22","conditions":"Homeostatic Iron Regulator Gene-related Hereditary Hemochromatosis","enrollment":84},{"nctId":"NCT06964776","phase":"PHASE1","title":"A Study of LY4268989 (MORF-057) in Healthy Participants","status":"COMPLETED","sponsor":"Eli Lilly and Company","startDate":"2025-05-01","conditions":"Healthy","enrollment":144},{"nctId":"NCT04864314","phase":"NA","title":"Assessment of TetraSOD® Efficacy to Improve Semen Parameters in Men With Idiopathic Infertility","status":"COMPLETED","sponsor":"Fitoplancton Marino, S.L.","startDate":"2021-05-12","conditions":"Infertility, Male","enrollment":80},{"nctId":"NCT03947827","phase":"PHASE3","title":"Minocycline as Adjunctive Treatment for Treatment Resistant Depression","status":"COMPLETED","sponsor":"Centre for Addiction and Mental Health","startDate":"2020-02-01","conditions":"Treatment Resistant Depression","enrollment":76},{"nctId":"NCT07496177","phase":"PHASE2","title":"A Mechanistic Study on the Effect of HTD1801 Versus Placebo on Kidney Function in Patients With Type 2 Diabetes and Chronic Kidney Disease.","status":"NOT_YET_RECRUITING","sponsor":"Institute of Medicinal Biotechnology, Chinese Academy of Medical Sciences","startDate":"2026-05-01","conditions":"T2DM, CKD","enrollment":75},{"nctId":"NCT06431932","phase":"PHASE1, PHASE2","title":"Pilot Trial of Fisetin in Healthy Volunteers and Older Patients With Multimorbidity","status":"RECRUITING","sponsor":"Ove Andersen","startDate":"2026-03-24","conditions":"Multimorbidity, Healthy","enrollment":60},{"nctId":"NCT04734080","phase":"PHASE4","title":"Dronabinol in Total Knee Arthroplasty (TKA)","status":"COMPLETED","sponsor":"Hospital for Special Surgery, New York","startDate":"2021-03-09","conditions":"Total Knee Arthroplasty, Opioid Use","enrollment":114},{"nctId":"NCT06968845","phase":"PHASE2","title":"A Phase 2 Study of LTI-03 in Patients With Idiopathic Pulmonary Fibrosis","status":"RECRUITING","sponsor":"Rein Therapeutics","startDate":"2026-02-02","conditions":"Idiopathic Pulmonary Fibrosis (IPF)","enrollment":120},{"nctId":"NCT07497698","phase":"NA","title":"Saffron Extract Supplementation and Sleep Quality in Middle-Aged Adults","status":"NOT_YET_RECRUITING","sponsor":"Universidad de Granada","startDate":"2026-03-01","conditions":"Sleep","enrollment":80},{"nctId":"NCT07111065","phase":"PHASE2","title":"FAST for DM - Fatty Acid Supplementation Trial (FAST) for Dermatomyositis (DM)","status":"NOT_YET_RECRUITING","sponsor":"National Institute of Environmental Health Sciences (NIEHS)","startDate":"2026-04-01","conditions":"Dermatomyositis (DM), Juvenile Dermatomyositis (JDM)","enrollment":300},{"nctId":"NCT05942911","phase":"PHASE2","title":"Safety and Effect on Pain and Function According to RAPID-3 of IHL-675A in Patients With Rheumatoid Arthritis","status":"TERMINATED","sponsor":"Incannex Healthcare Ltd","startDate":"2023-11-22","conditions":"Rheumatoid Arthritis","enrollment":20},{"nctId":"NCT07498751","phase":"PHASE1","title":"Phase I PK and Safety Study of Ondansetron Inhalation Powder","status":"COMPLETED","sponsor":"Luxena Pharmaceuticals, Inc.","startDate":"2025-03-13","conditions":"Postoperative Nausea and Vomiting","enrollment":24},{"nctId":"NCT07284316","phase":"PHASE2, PHASE3","title":"Effect of a Multidomain Intervention Plus Turmeric on the Prevention of Cognitive Decline in People Over 55 Years of Age With Insulin Resistance.","status":"ACTIVE_NOT_RECRUITING","sponsor":"Instituto Mexicano del Seguro Social","startDate":"2025-02-20","conditions":"Cognitive Decline, Subjective Cognitive Impairment, Insulin Resistance","enrollment":100},{"nctId":"NCT06610968","phase":"NA","title":"Acute Vitamin D Supplementation on Testosterone in Females","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of Southern California","startDate":"2025-07-01","conditions":"Female Hormone Profile","enrollment":20},{"nctId":"NCT00536185","phase":"NA","title":"Heart & Health Study","status":"COMPLETED","sponsor":"USDA, Western Human Nutrition Research Center","startDate":"2006-12","conditions":"Heart Disease","enrollment":166},{"nctId":"NCT04801849","phase":"PHASE2","title":"Vitamin E Dosing Study","status":"COMPLETED","sponsor":"National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)","startDate":"2022-08-05","conditions":"Nonalcoholic Fatty Liver Disease, Nonalcoholic Steatohepatitis","enrollment":200},{"nctId":"NCT04580472","phase":"PHASE4","title":"Utility of Single-dose Oral Antibiotic Prophylaxis in Prevention of Surgical Site Infection in Dermatologic Surgery","status":"ACTIVE_NOT_RECRUITING","sponsor":"Carilion Clinic","startDate":"2020-10-01","conditions":"Surgical Site Infection","enrollment":574},{"nctId":"NCT06843824","phase":"NA","title":"A Graphene Far-infrared Intervention Study of Cognitive Status in Older Adults","status":"COMPLETED","sponsor":"Institute of Psychology, Chinese Academy of Sciences","startDate":"2025-03-10","conditions":"Mild Cognitive Impairment (MCI), Subjective Cognitive Decrease (SCD), Alzheimer's Disease(AD)","enrollment":126},{"nctId":"NCT07209462","phase":"PHASE2","title":"Study of MRM-3379 in Male Participants With Fragile X Syndrome (BLOOM)","status":"RECRUITING","sponsor":"Mirum Pharmaceuticals, Inc.","startDate":"2025-11-22","conditions":"Fragile X Syndrome","enrollment":60},{"nctId":"NCT07492875","phase":"PHASE3","title":"Study of Nogapendekin Alfa Inbakicept and iNKT Cells in Critically Ill Adults With Severe Community-Acquired Pneumonia","status":"NOT_YET_RECRUITING","sponsor":"ImmunityBio, Inc.","startDate":"2026-04-15","conditions":"Community-Acquired Pneumonia (CAP), Acute Respiratory Distress Syndrome (ARDS), Sepsis","enrollment":10},{"nctId":"NCT07474831","phase":"NA","title":"Evaluation of the Ability of Lactobacillus Crispatus CRP21 to Reduce the Incidence of Recurrent Bacterial Vaginosis","status":"NOT_YET_RECRUITING","sponsor":"Liaquat University of Medical & Health Sciences","startDate":"2026-03-23","conditions":"Recurrent Bacterial Vaginosis","enrollment":156},{"nctId":"NCT07264192","phase":"PHASE1","title":"A Study of HS-10518 in Healthy Adult Premenopausal Females in China","status":"COMPLETED","sponsor":"West China Second University Hospital","startDate":"2025-03-11","conditions":"Infertility, Female","enrollment":60},{"nctId":"NCT07493850","phase":"PHASE2","title":"Study to Assess the Efficacy of EMC-CAP-2025A on Age-Related Skin Parameters in Healthy Individuals","status":"NOT_YET_RECRUITING","sponsor":"Circul'Egg","startDate":"2026-03-16","conditions":"Facial Wrinkles, Skin Hydration, Skin Elasticity","enrollment":60},{"nctId":"NCT07144293","phase":"PHASE2","title":"Improving Physical Ability and Cellular Senescence Elimination in HIV","status":"ACTIVE_NOT_RECRUITING","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2025-12-04","conditions":"HIV, Frailty, Prefrail","enrollment":82},{"nctId":"NCT04745143","phase":"PHASE2","title":"Monotherapy of an NMDA Enhancer for Schizophrenia","status":"RECRUITING","sponsor":"China Medical University Hospital","startDate":"2018-01-01","conditions":"Schizophrenia","enrollment":80},{"nctId":"NCT01712620","phase":"PHASE2","title":"Spironolactone for Pulmonary Arterial Hypertension","status":"RECRUITING","sponsor":"National Institutes of Health Clinical Center (CC)","startDate":"2014-01-10","conditions":"Pulmonary Arterial Hypertension","enrollment":70},{"nctId":"NCT06006559","phase":"PHASE2","title":"A Study to Assess the Efficacy, Safety and Pharmacokinetics of EYU688 in Patients With Dengue Fever","status":"RECRUITING","sponsor":"Novartis Pharmaceuticals","startDate":"2024-02-20","conditions":"Dengue","enrollment":108},{"nctId":"NCT06126224","phase":"PHASE3","title":"A Study to Assess Efficacy and Safety of KarXT for the Treatment of Psychosis Associated With Alzheimer's Disease (ADEPT-2)","status":"ACTIVE_NOT_RECRUITING","sponsor":"Karuna Therapeutics, Inc., a Bristol Myers Squibb company","startDate":"2023-08-28","conditions":"Psychosis Associated With Alzheimer's Disease","enrollment":500},{"nctId":"NCT07011732","phase":"PHASE3","title":"A Phase 3 Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Agitation Associated With Alzheimer's Disease (ADAGIO-1)","status":"RECRUITING","sponsor":"Bristol-Myers Squibb","startDate":"2025-07-10","conditions":"Alzheimer Disease","enrollment":352},{"nctId":"NCT03407079","phase":"PHASE2","title":"Effects of Sucralose on Drug Absorption and Metabolism (The SweetMeds Study)","status":"RECRUITING","sponsor":"National Institute on Alcohol Abuse and Alcoholism (NIAAA)","startDate":"2018-04-05","conditions":"Healthy Volunteers, Overweight","enrollment":150},{"nctId":"NCT05052853","phase":"PHASE2","title":"Early Intervention of Prodromal Schizophrenia Using an NMDA Enhancer","status":"RECRUITING","sponsor":"China Medical University Hospital","startDate":"2021-11-01","conditions":"Prodromal Schizophrenia","enrollment":48},{"nctId":"NCT07448519","phase":"NA","title":"Colonic Delivery of DIM and Perilla Oil on Gut Hormones and Food Intake in Obesity","status":"COMPLETED","sponsor":"Queen Mary University of London","startDate":"2023-06-13","conditions":"Obesity & Overweight, Appetite Regulation","enrollment":20},{"nctId":"NCT07029581","phase":"PHASE2","title":"Phase 2, Efficacy and Safety Study of ACP-204 in Lewy Body Dementia Psychosis","status":"RECRUITING","sponsor":"ACADIA Pharmaceuticals Inc.","startDate":"2025-08-06","conditions":"Lewy Body Dementia Psychosis","enrollment":180},{"nctId":"NCT06574360","phase":"PHASE2","title":"Dual Modulation of Sigma-1 and NMDA Receptors in the Treatment of Schizophrenia","status":"RECRUITING","sponsor":"China Medical University Hospital","startDate":"2024-09-23","conditions":"Schizophrenia","enrollment":90},{"nctId":"NCT06696755","phase":"PHASE2","title":"A Study to Assess Adverse Events and Change in Disease Activity of Oral Icalcaprant in Adult Participants With Bipolar I or II Disorder","status":"RECRUITING","sponsor":"AbbVie","startDate":"2026-02-03","conditions":"Bipolar I Disorder, Bipolar II Disorder","enrollment":195},{"nctId":"NCT05511363","phase":"PHASE3","title":"A Study to Assess Efficacy and Safety of KarXT for the Treatment of Psychosis Associated With Alzheimer's Disease (ADEPT-1)","status":"RECRUITING","sponsor":"Karuna Therapeutics, Inc., a Bristol Myers Squibb company","startDate":"2022-08-23","conditions":"Psychosis Associated With Alzheimer's Disease","enrollment":410},{"nctId":"NCT07065240","phase":"PHASE2","title":"A Study to Evaluate the Efficacy and Safety of SPT-300 (GlyphAllo) in Participants With Major Depressive Disorder, With or Without Anxious Distress (BUOY-1 Study)","status":"RECRUITING","sponsor":"Seaport Therapeutics","startDate":"2025-06-19","conditions":"Major Depressive Disorder (MDD), Major Depressive Disorder With Anxious Distress","enrollment":360},{"nctId":"NCT07341230","phase":"NA","title":"Deep Brain Stimulation to Understand and Treat Addiction","status":"RECRUITING","sponsor":"University of Cambridge","startDate":"2025-07-01","conditions":"Alcohol Use Disorder","enrollment":9},{"nctId":"NCT07300514","phase":"PHASE3","title":"Golidocitinib Versus Placebo as Maintenance Therapy for Peripheral T-Cell Lymphoma","status":"NOT_YET_RECRUITING","sponsor":"Fudan University","startDate":"2026-03-30","conditions":"Maintenance Treatment of Peripheral T-cell Lymphoma","enrollment":136},{"nctId":"NCT05240976","phase":"PHASE2","title":"Combination of NMDA-enhancing and Anti-inflammatory Treatments for Ultra-resistant Schizophrenia","status":"RECRUITING","sponsor":"China Medical University Hospital","startDate":"2022-02-23","conditions":"Schizophrenia","enrollment":80},{"nctId":"NCT05677763","phase":"PHASE4","title":"OM-85 in Paediatric Recurrent Respiratory Tract Infections With Wheezing Lower Respiratory Illness","status":"ACTIVE_NOT_RECRUITING","sponsor":"OM Pharma SA","startDate":"2022-12-12","conditions":"Respiratory Tract Infections, Wheezing Lower Respiratory Illness","enrollment":525},{"nctId":"NCT04150380","phase":"PHASE2","title":"Probiotic (LGG) for Veterans With PTSD","status":"COMPLETED","sponsor":"VA Eastern Colorado Health Care System","startDate":"2020-08-24","conditions":"Post Traumatic Stress Disorder, Inflammation","enrollment":383},{"nctId":"NCT07325266","phase":"PHASE2","title":"Human Laboratory Study of Apremilast for Alcohol Use Disorder","status":"NOT_YET_RECRUITING","sponsor":"National Institute on Alcohol Abuse and Alcoholism (NIAAA)","startDate":"2026-04-01","conditions":"Alcohol Use Disorder, Alcohol Misuse","enrollment":100},{"nctId":"NCT06948214","phase":"PHASE3","title":"Phase 3 Study of LUM-201 in Children With Growth Hormone Deficiency","status":"RECRUITING","sponsor":"Lumos Pharma","startDate":"2026-04","conditions":"Growth Hormone Deficiency (GHD)","enrollment":150},{"nctId":"NCT07276997","phase":"PHASE2","title":"A Study to Assess Change in Disease Activity and Adverse Events of Oral Icalcaprant in Adult Participants With Major Depressive Disorder","status":"RECRUITING","sponsor":"AbbVie","startDate":"2025-12-18","conditions":"Major Depressive Disorder","enrollment":195},{"nctId":"NCT07236190","phase":"PHASE1, PHASE2","title":"Biomarker-based Trial of NPC-1 for Alzheimer's Pathology","status":"NOT_YET_RECRUITING","sponsor":"Massachusetts General Hospital","startDate":"2026-03","conditions":"Alzheimer Disease, Mild Cognitive Impairment (MCI), Subjective Cognitive Complaints (SCCs)","enrollment":40},{"nctId":"NCT06346847","phase":"NA","title":"Study to Assess Effects of Postbiotic vs Placebo in Participants With Diarrhea-predominant IBS","status":"COMPLETED","sponsor":"A-Mansia Biotech S.A.","startDate":"2024-07-18","conditions":"Diarrhea-Predominant Irritable Bowel Syndrome","enrollment":384},{"nctId":"NCT07476573","phase":"NA","title":"Clinical Trial of Lactiplantibacillus Plantarum Dad-13 on Gut Microbiota Profile and Performance in Adolescent Athletes","status":"NOT_YET_RECRUITING","sponsor":"Gadjah Mada University","startDate":"2026-04-13","conditions":"Athlete, Probiotic, Performance","enrollment":30},{"nctId":"NCT06934915","phase":"EARLY_PHASE1","title":"Prednisone in Adults With an Immune-Mediated Subtype of Autism Spectrum Disorder","status":"NOT_YET_RECRUITING","sponsor":"Christopher John McDougle, M.D.","startDate":"2026-11","conditions":"Autism Spectrum Disorder, Autism Spectrum Disorders, Autistic Disorder","enrollment":32},{"nctId":"NCT07488975","phase":"PHASE1","title":"Developing Microbial Therapy for MASLD: From Mechanism to Clinical Validation","status":"RECRUITING","sponsor":"Leeuwenhoek Laboratories Co. Ltd.","startDate":"2025-01-22","conditions":"Metabolic Dysfunction-Associated Steatotic Liver Disease","enrollment":40},{"nctId":"NCT03804229","phase":"PHASE3","title":"Efficacy and Safety of Butylphthalide Soft Capsule for the Treatment of Vascular Dementia","status":"ACTIVE_NOT_RECRUITING","sponsor":"Capital Medical University","startDate":"2019-10-29","conditions":"Vascular Dementia","enrollment":707},{"nctId":"NCT04924608","phase":"PHASE3","title":"Efficacy and Safety of Selumetinib in Adults With NF1 Who Have Symptomatic, Inoperable Plexiform Neurofibromas","status":"ACTIVE_NOT_RECRUITING","sponsor":"AstraZeneca","startDate":"2021-11-19","conditions":"Neurofibromatosis 1, Plexiform Neurofibroma (PN)","enrollment":145},{"nctId":"NCT07487909","phase":"PHASE1, PHASE2","title":"A Study of SJP-001 in Comparison With Fexofenadine and Naproxen Administered With Alcohol","status":"COMPLETED","sponsor":"Sen-Jam Pharmaceutical","startDate":"2025-09-30","conditions":"Healthy","enrollment":47},{"nctId":"NCT06944145","phase":"PHASE2","title":"New Treatment Strategies and Epigenetic Biomarker for Management of Benign Prostatic Hyperplasia","status":"RECRUITING","sponsor":"Beth Israel Deaconess Medical Center","startDate":"2025-12-03","conditions":"BPH (Benign Prostatic Hyperplasia), Lower Urinary Track Symptoms","enrollment":242},{"nctId":"NCT05850091","phase":"PHASE4","title":"Polygenic Risk-based Detection of Subclinical Coronary Atherosclerosis and Intervention With Statin and Colchicine","status":"RECRUITING","sponsor":"Massachusetts General Hospital","startDate":"2023-12-07","conditions":"Coronary Artery Disease","enrollment":200},{"nctId":"NCT05364008","phase":"PHASE3","title":"FRIEND: Fibroids and Unexplained Infertility Treatment With Epigallocatechin Gallate; A Natural CompounD in Green Tea","status":"ACTIVE_NOT_RECRUITING","sponsor":"Yale University","startDate":"2023-01-05","conditions":"Leiomyoma, Uterine","enrollment":33},{"nctId":"NCT07485842","phase":"PHASE4","title":"FuKe Qianjin Capsule Plus Antibiotics for Chronic Endometritis","status":"NOT_YET_RECRUITING","sponsor":"Tianjin Medical University","startDate":"2026-04","conditions":"Chronic Endometritis","enrollment":300},{"nctId":"NCT07216482","phase":"PHASE3","title":"A Clinical Study of Enlicitide in Participants With High Cholesterol (MK-0616-037)","status":"RECRUITING","sponsor":"Merck Sharp & Dohme LLC","startDate":"2025-11-11","conditions":"Hyperlipidemia","enrollment":975},{"nctId":"NCT04597372","phase":"PHASE2","title":"Impact of Tamsulosin on Post-Operative Urinary Retention Following Pelvic Reconstructive Surgery","status":"RECRUITING","sponsor":"Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute)","startDate":"2021-11-03","conditions":"Urinary Retention Postoperative","enrollment":154},{"nctId":"NCT05405387","phase":"PHASE2","title":"Impact of Budesonide on Incidence of ≥ Gr2 Diarrhea in Multiple Myeloma (MM) Patients Undergoing Autologous Stem Cell Transplant","status":"RECRUITING","sponsor":"University of Utah","startDate":"2023-05-03","conditions":"Multiple Myeloma, Plasma Cell Leukemia","enrollment":120},{"nctId":"NCT05263206","phase":"PHASE3","title":"Efficacy and Safety of Subcutaneous Dupilumab for the Treatment of Adult Participants With Chronic Pruritus of Unknown Origin (CPUO) (LIBERTY-CPUO-CHIC)","status":"RECRUITING","sponsor":"Sanofi","startDate":"2022-02-15","conditions":"Pruritus","enrollment":284},{"nctId":"NCT03970720","phase":"PHASE2","title":"Restoration of Hypoglycemia Awareness With Metoclopramide","status":"RECRUITING","sponsor":"Simon Fisher","startDate":"2019-05-28","conditions":"Hypoglycemia Unawareness","enrollment":36},{"nctId":"NCT06517758","phase":"PHASE3","title":"A Phase III Study to Investigate Efficacy, Safety and Tolerability of Iptacopan Compared With Placebo in Participants Aged 18 to 85 Years With gMG.","status":"RECRUITING","sponsor":"Novartis Pharmaceuticals","startDate":"2024-07-31","conditions":"Generalized Myasthenia Gravis","enrollment":146},{"nctId":"NCT07310264","phase":"PHASE1","title":"Research Into the Safety of a New Agent (VT-5006) in People With and Without Parkinson's Disease","status":"RECRUITING","sponsor":"Vertero Therapeutics","startDate":"2025-10-30","conditions":"Healthy Volunteers (HV), Parkinson's Disease (PD)","enrollment":84},{"nctId":"NCT05421858","phase":"PHASE3","title":"A Phase 3 Efficacy and Safety Study of Fosmanogepix for the Treatment of Adult Participants With Candidemia and/or Invasive Candidiasis.","status":"RECRUITING","sponsor":"Basilea Pharmaceutica","startDate":"2024-12-11","conditions":"Candidemia, Candidiasis, Invasive","enrollment":450},{"nctId":"NCT07484412","phase":"NA","title":"Efficacy and Safety of Encapsulated Bifidobacterium Longum BBH016 in Subjects With Lower Gastrointestinal Symptoms","status":"ACTIVE_NOT_RECRUITING","sponsor":"Seoul National University Bundang Hospital","startDate":"2025-08-01","conditions":"Lower Abdominal Pain, Diarrhea, Irritable Bowel Syndrome","enrollment":88},{"nctId":"NCT05430152","phase":"PHASE2","title":"Low-dose Naltrexone for Post-COVID Fatigue Syndrome","status":"COMPLETED","sponsor":"Luis Nacul","startDate":"2024-01-15","conditions":"Post-Viral Fatigue Syndrome","enrollment":160},{"nctId":"NCT07485296","phase":"PHASE2","title":"Effect of Postbiotics on Microbiota and Systemic Immunomodulation of Pembrolizumab as First-Line Therapy in Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma (RM HNSCC)","status":"RECRUITING","sponsor":"Gruppo Oncologico del Nord-Ovest","startDate":"2026-01-27","conditions":"Head & Neck Squamous Cell Carcinoma","enrollment":45},{"nctId":"NCT07169318","phase":"PHASE1","title":"First-in-Human Study of VNT-101: Safety, Tolerability, and Pharmacokinetics","status":"RECRUITING","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2025-09-16","conditions":"Influenza","enrollment":78},{"nctId":"NCT06237452","phase":"PHASE3","title":"VE303 for Prevention of Recurrent Clostridioides Difficile Infection","status":"RECRUITING","sponsor":"Vedanta Biosciences, Inc.","startDate":"2024-05-20","conditions":"Clostridium Difficile, Clostridium Difficile Infections, Clostridium Difficile Infection Recurrence","enrollment":852},{"nctId":"NCT04191096","phase":"PHASE3","title":"Efficacy and Safety of Pembrolizumab (MK-3475) Plus Enzalutamide Plus Androgen Deprivation Therapy (ADT) Versus Placebo Plus Enzalutamide Plus ADT in Participants With Metastatic Hormone-Sensitive Prostate Cancer (mHSPC) (MK-3475-991/KEYNOTE-991)","status":"ACTIVE_NOT_RECRUITING","sponsor":"Merck Sharp & Dohme LLC","startDate":"2020-02-12","conditions":"Metastatic Hormone-Sensitive Prostate Cancer","enrollment":1251},{"nctId":"NCT06307652","phase":"PHASE3","title":"Study to Evaluate the Effect of Balcinrenone/Dapagliflozin in Patients With Heart Failure and Impaired Kidney Function","status":"RECRUITING","sponsor":"AstraZeneca","startDate":"2024-04-12","conditions":"Heart Failure and Impaired Kidney Function","enrollment":4800},{"nctId":"NCT07481578","phase":"NA","title":"Impact of Training Load on the Gut miCrobiome And Its Relation to exeRcise Performance, mUscle Phenotype, and markerS of Overreaching in Healthy Men","status":"RECRUITING","sponsor":"Stefan De Smet","startDate":"2024-10-07","conditions":"Exercise, Overreaching, Butyrate","enrollment":45},{"nctId":"NCT07483632","phase":"PHASE3","title":"A Study to Learn About the Safety of Diroximel Fumarate (DRF) and Dimethyl Fumarate (DMF) and Their Effects on Relapses in Pediatric Participants With Relapsing Forms of Multiple Sclerosis (RMS)","status":"NOT_YET_RECRUITING","sponsor":"Biogen","startDate":"2026-11-16","conditions":"Relapsing Forms of Multiple Sclerosis","enrollment":185},{"nctId":"NCT04614714","phase":"PHASE2, PHASE3","title":"Milk Volume Outcomes Following Oral Nicotinamide Riboside Supplementation in Mothers of Extremely Preterm Infants","status":"NOT_YET_RECRUITING","sponsor":"University of California, Davis","startDate":"2026-04-01","conditions":"Preterm Birth, Inadequate Milk Production","enrollment":40},{"nctId":"NCT07482644","phase":"NA","title":"Efficacy and Safety of an Essential Oil-Based Product System for Immune Support","status":"NOT_YET_RECRUITING","sponsor":"dōTERRA International","startDate":"2026-05-04","conditions":"Immune System Function, Inflammation","enrollment":40},{"nctId":"NCT07481981","phase":"PHASE3","title":"A Study to Evaluate the Efficacy and Safety of Once Daily Treprostinil Palmitil Inhalation Powder (TPIP) in Participants With Pulmonary Arterial Hypertension (PAH)","status":"NOT_YET_RECRUITING","sponsor":"Insmed Incorporated","startDate":"2026-04-17","conditions":"Pulmonary Arterial Hypertension","enrollment":344},{"nctId":"NCT04924166","phase":"PHASE2","title":"PTSD Prevention Using Oral Hydrocortisone","status":"COMPLETED","sponsor":"Rachel Yehuda","startDate":"2022-01-12","conditions":"PTSD, Acute Stress Disorder, Trauma-related Stressor","enrollment":201},{"nctId":"NCT07351968","phase":"PHASE1","title":"A Phase Ib Study to Evaluate the Efficacy and Safety of HRS-2129 in Patients With Knee Osteoarthritis","status":"RECRUITING","sponsor":"Shandong Suncadia Medicine Co., Ltd.","startDate":"2026-03-10","conditions":"Moderate Pain in Knee Osteoarthritis, Severe Pain in Knee Osteoarthritis","enrollment":200},{"nctId":"NCT07181382","phase":"PHASE3","title":"Efficacy and Safety of Seralutinib in Adult Subjects With Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)","status":"SUSPENDED","sponsor":"GB002, Inc.","startDate":"2026-02","conditions":"Pulmonary Hypertension Associated With Interstitial Lung Disease","enrollment":480},{"nctId":"NCT03850964","phase":"PHASE2, PHASE3","title":"Effects of Pazopanib on Hereditary Hemorrhagic Telangiectasia Related Epistaxis and Anemia (Paz)","status":"ACTIVE_NOT_RECRUITING","sponsor":"Cure HHT","startDate":"2023-05-08","conditions":"Hereditary Hemorrhagic Telangiectasia, Epistaxis, Anemia","enrollment":70},{"nctId":"NCT07479173","phase":"NA","title":"Effects of P24 on Postprandial Aminoacidemia","status":"NOT_YET_RECRUITING","sponsor":"Amplifye","startDate":"2026-05-01","conditions":"Postprandial Amino Acid Concentrations in Healthy Adults","enrollment":30},{"nctId":"NCT04675788","phase":"PHASE4","title":"Novel Approaches for Minimizing Drug-Induced QT Interval Lengthening","status":"COMPLETED","sponsor":"Indiana University","startDate":"2021-09-02","conditions":"Long QT Syndrome, Abnormalities, Drug-Induced","enrollment":73},{"nctId":"NCT07267559","phase":"PHASE4","title":"Dual Orexin Antagonism and Emotion and Affective Processing Study","status":"RECRUITING","sponsor":"University of Oxford","startDate":"2025-10-01","conditions":"Learning, Cognitive Functioning, Emotional Processing","enrollment":62}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":3,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Calcined magnesium","Placebo","placebo","Placebo vaginal capsule","Study Drug"],"phase":"marketed","status":"active","brandName":"Placebo - Cap","genericName":"Placebo - Cap","companyName":"Ain Shams University","companyId":"ain-shams-university","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Placebo produces no pharmacological effect and works through psychological expectation and the placebo response. Used for Clinical trial control / comparator.","enrichmentLevel":3,"visitCount":1,"trialStats":{"total":14,"withResults":7},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}